Viva Biotech Holdings (HK:1873) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Viva Biotech Holdings has successfully adopted its Viva Shanghai Phase I and Phase II Share Option Schemes, with shareholders’ approval leading to the immediate effectivity of both schemes. The company has updated its share option grants, now extending 7,320,000 Phase I and Phase II share options to 11 and 21 incentive participants respectively, with slight adjustments due to personnel changes. These grants are set to be formalized and implemented for the incentive participants on June 14, 2024.
For further insights into HK:1873 stock, check out TipRanks’ Stock Analysis page.